IP Library Granted Patent US 7,723,550
Granted Patent B2
US 7,723,550 · App. 12/224,418 · Granted May 25, 2010

Process for preparing organic compounds

Assignee: Novartis AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,723,550
App. No.
12/224,418
Granted
May 25, 2010
Kind
B2
Abstract

Process for preparing a compound of the formula (I) in which R 1 and R 2 are each independently H, C 1 -C 8 -alkyl, halogen, polyhalo-C 1 -C 8 -alkoxy, polyhalo-C 1 -C 8 -alkyl, C 1 -C 8 -alkoxy, C 1 -C 8 -alkoxy-C 1 -C 8 -alkyl, or C 1 -C 8 -alkoxy-C 1 -C 8 -alkoxy, where R 1 and R 2 are not both H, and R 3 is C 1 -C 8 -alkyl, which is characterized in that a) a compound of the formula (II) in which R 1 and R 2 are each as defined above and X is Br, I, triflate, toyslate or mesylate is reacted with prop-2-yn-1-ol to give the compound of the formula (III), b) the compound of the formula (III) is reacted with an alkyl-metal compound in which “alkyl” is as defined above for R 3 to give a compound of the formula (I).

Claims (27)

1. Process for preparing a compound of the formula I

in which

R 1 is a linear or branched C 1 -C 8 -alkoxy-C 1 -C 8 -alkoxy radical,

R 2 is a linear or branched C 1 -C 8 -alkyl radical or a linear or branched C 1 -C 8 -alkoxy radical, and

R 3 is isopropyl,

which is characterized in that

a) a compound of the formula II

in which R 1 and R 2 are each as defined above and X is Br, I, triflate, toyslate or mesylate is reacted with prop-2-yn-1-ol to give the compound of the formula III

b) the compound of the formula III is reacted with an alkyl-metal compound in which “alkyl” is as defined above for R 3 to give a compound of the formula I.

2. Process according to claim 1 , wherein R 1 is methoxy- or ethoxy-C 1 -C 4 -alkoxy, and R 2 is methyl, ethyl, methoxy or ethoxy.

3. Process according to claim 1 , wherein R 1 is 3-methoxypropoxy or 4-methoxybutoxy and R 2 is methyl or methoxy.

4. Process according to claim 1 , wherein R 1 is 3-methoxypropoxy and R 2 is methoxy.

5. Compound of the formula III

in which R 1 is methoxypropoxy, and R 2 is methoxy.

6. Process according to claim 1 , wherein the compound of the formula (I) prepared according to claim 1 is converted by asymmetric hydrogenation to a compound of the formula D

in which

R 1 is a linear or branched C 1 -C 8 -alkoxy-C 1 -C 8 -alkoxy radical,

R 2 is a linear or branched C 1 -C 8 -alkyl radical or a linear or branched C 1 -C 8 -alkoxy radical, and

R 3 is isopropyl,

the compound of the formula D is converted by halogenation to a compound of the formula B

where Y is Cl, Br or I,

the compound of the formula B is reacted with a compound of the formula C,

in which R 4 is C 1 -C 8 -alkyl, R 5 is C 1 -C 8 -alkyl or C 1 -C 8 -alkoxy, R 6 is C 1 -C 8 -alkyl, or R 5 and R 6 together are optionally C 1 -C 4 -alkyl-, phenyl- or benzyl-substituted tetramethylene, pentamethylene, 3-oxa-1,5-pentylene or —CH 2 CH 2 O—C(O)—, and Z is Cl, Br or I,

in the presence of an alkali metal or alkaline earth metal, to give a compound of the formula A

7. Process according to claim 6 , wherein R 1 is methoxy- or ethoxy-C 1 -C 4 -alkoxy, and R 2 is methyl, ethyl, methoxy or ethoxy.

8. Process according to claim 6 , wherein R 1 is 3-methoxypropoxy or 4-methoxybutoxy and R 2 is methyl or methoxy.

9. Process according to claim 6 , wherein R 1 is 3-methoxypropoxy and R 2 is methoxy.

Assignments (3)
MERGER Recorded Apr 23, 2010
From: SPEEDEL EXPERIMENTA AG
To: NOVARTIS PHARMA AG
Reel/Frame 024276/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2010
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 024276/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2008
From: HEROLD, PETER; MAH, ROBERT; STUTZ, STEFAN; STOJANOVIC, ALEKSANDAR; LYOTHIER, ISABELLE; BEHNKE, DIRK
To: SPEEDEL EXPERIMENTA AG
Reel/Frame 021476/0455 →
Priority Claims (1)
EP 06123706 · Nov 8, 2006 · regional
Continuity (1)
Related Publication 20090105503A1 · Apr 23, 2009